Joshua Dennerlein analyst BAML

Currently out of the existing stock ratings of Joshua Dennerlein, 32 are a SELL (19.88%), 62 are a HOLD (38.51%), 67 are a BUY (41.61%).

Joshua Dennerlein

Work Performance Price Targets & Ratings Chart

Analyst Joshua Dennerlein, currently employed at BAML, carries an average stock price target met ratio of 65.94% that have a potential upside of 25.84% achieved within 463 days.

Joshua Dennerlein’s has documented 304 price targets and ratings displayed on 36 stocks. The coverage is on Industrials, Technology, Financial Services, Utilities sectors.

Most recent stock forecast was given on CTAS, Cintas at 15-Jul-2026.

Wall Street Analyst Joshua Dennerlein

Analyst best performing recommendations are on AHR (AMERICAN HEALTHCARE REIT).
The best stock recommendation documented was for AHR (AMERICAN HEALTHCARE REIT) at 8/8/2024. The price target of $19 was fulfilled within 14 days with a profit of $3.19 (20.18%) receiving and performance score of 14.41.

Average potential price target upside

COLD Americold Realty Trust EPRT Essential Properties Realty Trust MPW Medical Properties Trust OHI Omega Healthcare Investors PEAK Healthpeak Properties SBRA Sabra Healthcare REIT SRC Spirit Realty Capital VTR Ventas WELL Welltower ADC Agree Realty CPT Camden Property Trust DOC Physicians Realty Trust NNN National Retail Properties GTY Getty Realty NTST Netstreit Corp SAFE Safehold VER VEREIT EPR EPR Properties MAA Mid-America Apartment Communities O Realty ome Corp SUI Sun Communities WPC W P Carey ESS Essex Property Trust AHR American Healthcare REIT CTAS Cintas EFX Equifax FICO Fair Isaac FVR FrontView REIT KW Kennedy-Wilson Holdings LINE Lineage MCO Moodys MP MP Materials Corp MSCI MSCI SR Spire UDR UDR VRE Veris Residential

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-Oct-2025

$14

$-0.47 (-3.25%)

$16

8 days ago
(20-Oct-2026)

3/5 (60%)

$-0.1 (-0.71%)

99

Hold Since 01-Apr-2026

$15

$0.53 (3.66%)

$17

16 days ago
(12-Oct-2026)

1/3 (33.33%)

$1.01 (7.22%)

36

Hold Since 05-Sep-2025

$16

$1.53 (10.57%)

$16

26 days ago
(02-Oct-2026)

4/14 (28.57%)

$2.03 (14.53%)

105

Sell Since 14-Nov-2025

$16

$1.53 (10.57%)

$14

1 months 4 days ago
(24-Sep-2026)

4/11 (36.36%)

$1.87 (13.23%)

143

Buy Since 21-Sep-2026

$18

$3.53 (24.40%)

$16

1 months 7 days ago
(21-Sep-2026)

3/14 (21.43%)

$3.5 (24.14%)

65

Show more analysts

Please expand the browser size to see the chart

Which stock is Joshua Dennerlein most bullish on?

Potential upside of $32.32 has been obtained for CTAS (CINTAS)

What Year was the first public recommendation made by Joshua Dennerlein?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?